NCT02578472View on ClinicalTrials.gov

Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Healthy
Interventions
DRUG

JNJ-42847922

JNJ-42847922 will be administered as 40 milligram oral capsule (2 capsule\*20 mg) in one of the treatment periods.

DRUG

Zolpidem

Zolpidem will be administered as 1 capsule containing 10 mg in one of the treatment periods.

DRUG

Placebo

Matching Placebo will be administered orally.

Trial Locations (1)

Unknown

Leiden

Sponsors
All Listed Sponsors
lead

Janssen-Cilag International NV

INDUSTRY

NCT02578472 - Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants | Biotech Hunter | Biotech Hunter